Lexaria Bioscience Corp. Discusses The Significance of Their Intellectual Property with The Stock Day Podcast

The Stock Day Podcast welcomed Lexaria Bioscience Corp. (LXRP)(“the Company”), known for its proprietary drug delivery technology, DehydraTECH™, which improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. CEO of the Company, Chris Bunka, joined Stock Day host Everett Jolly. READ FULL PRESS RELEASE HERE: https://stockdaymedia.com/lexaria-bioscience-corp-discusses-the-significance-of-their-intellectual-property-with-the-stock-day-podcast-lxrp-november-17-2020/ Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy